New cancer clinical trial: Limited Adjuvant Endocrine Therapy for Low Risk Breast Cancer

Published on: April 16, 2019 at 12:00PM
Conditions:   Breast Cancer Female;   Hormone Receptor Positive Tumor
Intervention:   Drug: Tamoxifen Citrate
Sponsors:   British Columbia Cancer Agency;   Canadian Cancer Society Research Institute (CCSRI);   NanoString Technologies, Inc.
Not yet recruiting
http://bit.ly/2XkqK02